Targeted blockage of signal transducer and activator of transcription 5 signaling pathway with decoy oligodeoxynucleotides suppresses leukemic K562 cell growth

DNA and Cell Biology

Volumn 30, Issue 2, 2011, Pages 71-78

  Wang, Xiaozhong ^a,b   Zeng, Jianming ^a   Shi, Mei ^a   Zhao, Shiqiao ^a   Bai, Weijun ^a   Cao, Weixi ^a   Tu, Zhiguang ^c   Huang, Zonggan ^c   Feng, Wenli ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b NANCHANG UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; CYCLIN D1; DECOY OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; MYC PROTEIN; OLIGODEOXYNUCLEOTIDE DERIVATIVE; PROTEIN BCL XL; STAT5 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG TARGETING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; BASE SEQUENCE; BCL-X PROTEIN; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA; OLIGODEOXYRIBONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUBSTRATE SPECIFICITY; TRANSCRIPTIONAL ACTIVATION;

EID: 79551638801     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1112     Document Type: Article

References (26)

1. Azam, M., Latek, R.R., and Daley, G.Q. (2003). Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 112, 831-843.
2. Azuma, H., Tomita, N., Kaneda, Y., Koike, H., Ogihara, T., Katsuoka, Y., and Mor-ishita, R. (2003). Transfection of NFkappaBdecoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 10, 415-425.
3. Baśkiewicz-Masiuk, M., and Machaliń ski, B. (2004). The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. Eur J Haematol 72, 420-429.
4. Birkenkamp, K.U., Geugien, M., Lemmink, H.H., Kruijer, W., and Vellenga, E. (2001). Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia 15, 1923-1931.
5. Chae, Y.M., Park, K.K., Magae, J., Lee, I.S., Kim, C.H., Kim, H.C., Hong, S., and Chang, Y.C. (2004). Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation. Biochem Biophys Res Commun 319, 550-555.
6. Chalfant, C.E., Rathman, K., Pinkerman, R.L., Wood, R.E., Obeid, L.M., Ogretmen, B., and Hannun, Y.A. (2002). De Novo ceramide regulates the alternative splicing of caspase 9 and bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 277, 12587-12595.
7. Cho, J.M., Song, D.J., Bergeron, J., Benlimame, N., Wold, M.S., and Alaoui-Jamali, M.A. (2000). RBT1, a novel transcriptional co-activator, binds the second subunit of replication protein A. Nucl Acids Res 28, 3478-3485.
8. Darwish, H., Cho, J.M., Loignon, M., and Alaoui-Jamali, M.A. (2007). Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth. Oncogene 26, 4319-4328.
9. deGroot, R.P.,Raaijmakers, J.A., Lammers, J.W., andKoenderman, L. (2000). STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells. Mol Cell Biol Res Commun 3, 299-305.
10. Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., and Kantarjian, H.M. (1999). The biology of chronic myeloid leukemia. N Engl J Med 341, 164-172.
11. Ilaria, R.L., Hawley, R.G., and Van Etten, R.A. (1999). Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood 93, 4154-4166.
12. Kiaris, H., and Schally, A.V. (1999). Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci USA 96, 226-231.
13. Lord, J.D., McIntosh, B.C., Greenberg, P.D., and Nelson, B.H. (2000). The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol 164, 2533-2541.
14. Nam, S., Williams, A., Vultur, A., List, A., Bhalla, K., Smith, D., Lee, F.Y., and Jove, R. (2007). Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells. Mol Cancer Ther 6, 1400-1405.
15. Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A.L., and Kitamura, T. (1999). STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J 18, 4754-4765.
16. Rascle, A., and Lees, E. (2003). Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription. Nucleic Acids Res 31, 6882-6890.
17. Soldaini, E., John, S., Moro, S., Bollenbacher, J., Schindler, U., and Leonard, W.J. (2000). DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol Cell Biol 20, 389-401.
18. Strout, M.P., and Schatz, D.G. (2009). Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way. Cancer Cell 16, 174-176.
19. Tang, D., Kang, R., Xiao, W., Jiang, L., Liu, M., Shi, Y., Wang, K., Wang, H., and Xiao, X. (2007). Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)- induced HMGB1 cytoplasmic translocation and release. J Immunol 178, 7376-7384.
20. Wandji, S.A., Gadsby, J.E., Simmen, F.A., Barber, J.A., and Hammond, J.M. (2000). Porcine ovarian cells express messenger ribonucleic acids for the acid-labile subunit and insulinlike growth factor binding protein-3 during follicular and luteal phases of the estrous cycle. Endocrinology 141, 2638-2647.
21. Welte, T., Leitenberg, D., Dittel, B.N., al-Ramadi, B.K., Xie, B., Chin, Y.E., Janeway, C.A., Jr., Bothwell, A.L., Bottomly, K., and Fu, X.Y. (1999). STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283, 222-225.
22. Xi, S., Zhang, Q., Gooding, W.E., Smithgall, T.E., and Grandis, J.R. (2003). Constitutive activation of STAT5b contributes to carcinogenesis in vivo. Cancer Res 63, 6763-6771.
23. Xie, S., Lin, H., Sun, T., and Arlinghaus, R.B. (2002). Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 21, 7137-7146.
24. Xiuli, W., Su-ping, H., Hui-hua, D., Zhi-xue, Y., Shi-long, F., and Pin-hong, L. (2009). NF-kappaB decoy oligonucleotides suppress RANTES expression and monocyte chemotactic activity via NF-kappaB inactivation in stromal cells of ectopic endometrium. J Clin Immunol 29, 387-395.
25. Ye, D., Wolff, N., Li, L., Zhang, S., and Ilaria, R.L., Jr. (2006). STAT5 signaling is required for the efficient induction and maintenance of CML in mice. Blood 107, 4917-4925.
26. Zhang, X., Liu, P., Zhang, B., Wang, A., and Yang, M. (2010). Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells. Cancer Genet Cytogenet 197, 46-53.